Previous 10 | Next 10 |
Oncolytics Biotech® Announces Full Exercise of Over-Allotment Option from Public Offering Canada NewsWire CALGARY, AB , Sept. 7, 2023 /CNW/ -- Oncolytics Biotech ® Inc. (" Oncolytics " or the " Company ") (NASDAQ: ONCY) (TSX: ONC) today anno...
Oncolytics Biotech® to Participate in a Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference Canada NewsWire SAN DIEGO and CALGARY, AB , Sept. 6, 2023 /CNW/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC) today an...
2023-08-21 07:00:51 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips A handful of stocks to buy under $20 can offer investors explosive returns in uncertain market conditions. The article lists names that might not immediately grab headlines, but their strategic...
2023-08-14 11:48:09 ET Oncolytics Biotech Inc. (ONCY) Q2 2023 Earnings Conference Call August 14, 2023, 8:30 AM ET Company Participants Jon Patton - Director-Investor Relations and Communications Matt Coffey - President and Chief Executive Officer Thomas Heineman...
2023-08-14 09:05:45 ET Oncolytics Biotech press release ( NASDAQ: ONCY ): Q2 GAAP EPS of -C$0.12. C$24.4 million in cash, cash equivalents and marketable securities as of June 30, 2023 provides projected runway into H2 2024. Strengthened financial position with a...
Oncolytics Biotech® Reports Second Quarter 2023 Financial Results and Operational Highlights Canada NewsWire Phase 2 data from randomized BRACELET-1 trial in HR+/HER2- metastatic breast cancer showed a near tripling of confirmed ORR, >50% improvement in PFS, and 7...
2023-08-11 11:58:06 ET Oncolytics Biotech ( NASDAQ: ONCY ) is scheduled to announce Q2 earnings results on Monday, August 14th, before market open. The consensus EPS Estimate is -$0.08 . Over the last 3 months, EPS estimates have seen 3 upward revisions and 0 downw...
2023-08-11 09:56:34 ET Major earnings expected before the bell on Monday include: Atossa Therapeutics ( ATOS ) JinkoSolar Holding ( JKS ) Niu Technologies ( NIU ) Sundial Growers ( SNDL ) 22nd Century Group ( XXII ) For further details see: ...
Oncolytics Biotech® Successfully Raises US$15 Million to Advance Breast and Pancreatic Cancer Clinical Programs Canada NewsWire CALGARY, Alberta , Aug. 8, 2023 /CNW/ -- Oncolytics Biotech ® Inc. (" Oncolytics " or the " Company ") (NASDAQ: O...
Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 43rd Annual Growth Conference Canada NewsWire SAN DIEGO and CALGARY, AB , Aug. 4, 2023 /CNW/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that...
News, Short Squeeze, Breakout and More Instantly...
Oncolytics Biotech Inc. Company Name:
ONCY Stock Symbol:
NASDAQ Market:
Oncolytics Biotech Inc. Website:
Oncolytics Biotech® Announces Productive FDA Type C Meeting on its Metastatic Breast Cancer Program Canada NewsWire Clear path forward on key elements of the planned potential registration-enabling trial in HR+/HER2- metastatic breast cancer On track to report ove...
Oncolytics Biotech® Announces President and Chief Executive Officer Dr. Matt Coffey to Take Medical Leave of Absence Canada NewsWire Wayne Pisano , Chair of Oncolytics' Board of Directors, to serve as interim CEO Overall Survival data from BRACELET-1 breast ca...
2024-06-20 17:01:11 ET USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 20,2024 – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number o...